Overview

Bryophyllum vs. Nifedipine

Status:
Unknown status

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

Summary

In a prospective, randomised study the efficacy and tolerability of bryophyllum p. (p.o) vs. nifedipine (p.o) will be proofed in a defined group of pregnant women with threatened preterm labour.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Weleda AG

Treatments:

Nifedipine